<p class="title">The doctor who treated the first COVID-19 patient in the United States said Monday he fears a second outbreak of the <a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates"><b>coronavirus</b></a> disease when lockdown measures are lifted.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-live-news-updates-total-COVID-19-cases-deaths-India-may-2-lockdown-mumbai-bengaluru-delhi-ahmedabad-kolkata-maharashtra-karnataka-red-orange-zone-832551.html"><b>Track live updates on coronavirus here</b></a></p>.<p class="bodytext">George Díaz's first patient, diagnosed in January in Washington state, has already recovered after receiving remdesivir, an experimental drug that the US approved on Friday for emergency use.</p>.<p class="bodytext">While he feels encouraged by this anti-viral, Diaz emphasized that isolation to avoid contagion remains the "most effective" treatment for COVID-19 right now.</p>.<p class="bodytext">Since that first case in January, the US has overtaken all other countries to have by far the highest caseload -- about 1.2 million -- as well as the most deaths, around 69,000.<br /><b>Also Read: </b><a href="https://www.deccanherald.com/national/coronavirus-india-update-state-wise-total-number-of-confirmed-cases-deaths-on-may-5-833665.html"><b>Coronavirus India update: State-wise total number of confirmed cases</b></a></p>.<p class="bodytext">Despite forecasts of a worsening death toll, some states are already reopening to try to ease the economic strain of shelter-in-place orders that have put more than 30 million Americans out of work in six weeks.</p>.<p class="bodytext">"What worries me is that when the economy starts to reopen, we are going to see a second outbreak that is perhaps as big as the first, and the first one was very difficult for us and for the whole world," Díaz told reporters during a video meeting organized by the State Department.</p>.<p class="bodytext">"And more than anything, I am concerned that I don't know if we are going to have the resources to handle a second outbreak," he added.</p>.<p class="bodytext">Remdesivir, made by Gilead Sciences, was shown in a major clinical trial to shorten the time to recovery in some coronavirus patients.</p>.<p class="bodytext">Diaz said that, pending development of a vaccine, remdesivir appears to act against the virus, but he cautioned that the drug must be used very wisely.</p>.<p class="bodytext">It should not be a crutch for people to say, "'I can now do whatever I want because we have a treatment.' No," Diaz warned.</p>.<p class="bodytext">They must continue to follow guidance on social distancing, he said.</p>
<p class="title">The doctor who treated the first COVID-19 patient in the United States said Monday he fears a second outbreak of the <a href="https://www.deccanherald.com/coronavirus-live-news-covid-19-latest-updates"><b>coronavirus</b></a> disease when lockdown measures are lifted.</p>.<p><a href="https://www.deccanherald.com/national/coronavirus-live-news-updates-total-COVID-19-cases-deaths-India-may-2-lockdown-mumbai-bengaluru-delhi-ahmedabad-kolkata-maharashtra-karnataka-red-orange-zone-832551.html"><b>Track live updates on coronavirus here</b></a></p>.<p class="bodytext">George Díaz's first patient, diagnosed in January in Washington state, has already recovered after receiving remdesivir, an experimental drug that the US approved on Friday for emergency use.</p>.<p class="bodytext">While he feels encouraged by this anti-viral, Diaz emphasized that isolation to avoid contagion remains the "most effective" treatment for COVID-19 right now.</p>.<p class="bodytext">Since that first case in January, the US has overtaken all other countries to have by far the highest caseload -- about 1.2 million -- as well as the most deaths, around 69,000.<br /><b>Also Read: </b><a href="https://www.deccanherald.com/national/coronavirus-india-update-state-wise-total-number-of-confirmed-cases-deaths-on-may-5-833665.html"><b>Coronavirus India update: State-wise total number of confirmed cases</b></a></p>.<p class="bodytext">Despite forecasts of a worsening death toll, some states are already reopening to try to ease the economic strain of shelter-in-place orders that have put more than 30 million Americans out of work in six weeks.</p>.<p class="bodytext">"What worries me is that when the economy starts to reopen, we are going to see a second outbreak that is perhaps as big as the first, and the first one was very difficult for us and for the whole world," Díaz told reporters during a video meeting organized by the State Department.</p>.<p class="bodytext">"And more than anything, I am concerned that I don't know if we are going to have the resources to handle a second outbreak," he added.</p>.<p class="bodytext">Remdesivir, made by Gilead Sciences, was shown in a major clinical trial to shorten the time to recovery in some coronavirus patients.</p>.<p class="bodytext">Diaz said that, pending development of a vaccine, remdesivir appears to act against the virus, but he cautioned that the drug must be used very wisely.</p>.<p class="bodytext">It should not be a crutch for people to say, "'I can now do whatever I want because we have a treatment.' No," Diaz warned.</p>.<p class="bodytext">They must continue to follow guidance on social distancing, he said.</p>